Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet E Dancey

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Nature Reviews. Drug Discovery|August 3, 2006
Strategies for optimizing combinations of molecularly targeted anticancer agentsJanet E Dancey, Helen X Chen
Seminars in Oncology|December 8, 2009
Evaluating temsirolimus activity in multiple tumors: a review of clinical trialsJanet E Dancey, Rafael Curiel, Joseph Purvis
Frontiers in Pharmacology|December 25, 2023
Minding the gaps: assessing and addressing clinical research core competencies across a network of Canadian cancer centresStephen Sundquist, Diana Kato, Raisa Chowdhury, et al.
The Lancet. Oncology|February 13, 2016
Rare cancers: a sea of opportunityNiki Boyd, Janet E Dancey, C Blake Gilks, et al.
Cell|February 7, 2012
The genetic basis for cancer treatment decisionsJanet E Dancey, Philippe L Bedard, Nicole Onetto, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer CentersStephen Sundquist, Diana Kato, Rebecca Y Xu, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
Advancing Academic Cancer Clinical Trials Recruitment in CanadaRebecca Y Xu, Diana Kato, Gregory R Pond, et al.
Journal of the National Cancer Institute|October 27, 2009
A perspective on challenges and issues in biomarker development and drug and biomarker codevelopmentSheila E Taube, Gary M Clark, Janet E Dancey, et al.
Cancers|December 30, 2025
The Outcome and Impact of Academic Cancer Clinical Trials with Participation from Canadian Sites (2015-2024)Rebecca Y Xu, Diana Kato, Victoria Percival, et al.
Leukemia Research|March 6, 2009
Phase II trial of temsirolimus in patients with relapsed or refractory multiple myelomaSherif S Farag, Shuhong Zhang, Buffy S Jansak, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Nature Reviews. Drug Discovery|August 3, 2006
Strategies for optimizing combinations of molecularly targeted anticancer agentsJanet E Dancey, Helen X Chen
Seminars in Oncology|December 8, 2009
Evaluating temsirolimus activity in multiple tumors: a review of clinical trialsJanet E Dancey, Rafael Curiel, Joseph Purvis
Frontiers in Pharmacology|December 25, 2023
Minding the gaps: assessing and addressing clinical research core competencies across a network of Canadian cancer centresStephen Sundquist, Diana Kato, Raisa Chowdhury, et al.
The Lancet. Oncology|February 13, 2016
Rare cancers: a sea of opportunityNiki Boyd, Janet E Dancey, C Blake Gilks, et al.
Cell|February 7, 2012
The genetic basis for cancer treatment decisionsJanet E Dancey, Philippe L Bedard, Nicole Onetto, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer CentersStephen Sundquist, Diana Kato, Rebecca Y Xu, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
Advancing Academic Cancer Clinical Trials Recruitment in CanadaRebecca Y Xu, Diana Kato, Gregory R Pond, et al.
Journal of the National Cancer Institute|October 27, 2009
A perspective on challenges and issues in biomarker development and drug and biomarker codevelopmentSheila E Taube, Gary M Clark, Janet E Dancey, et al.
Cancers|December 30, 2025
The Outcome and Impact of Academic Cancer Clinical Trials with Participation from Canadian Sites (2015-2024)Rebecca Y Xu, Diana Kato, Victoria Percival, et al.
Leukemia Research|March 6, 2009
Phase II trial of temsirolimus in patients with relapsed or refractory multiple myelomaSherif S Farag, Shuhong Zhang, Buffy S Jansak, et al.
Pageof 5